Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer LtdfiledCriticalPfizer Ltd
Publication of GEP20043348BpublicationCriticalpatent/GEP20043348B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
1. Technical Result Increase in efficiency of impotence treatment. 2. Essence A compound of the formula, radicals of which are provided in the description, and pharmaceutical composition on its base, their use in medicaments production for treating and prevention of erectile dysfunction in a male human. 3. Field of Application Medicine.
Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system
WATER-SOLUBLE DERIVATIVES OF EPIPODOFILOTOXINA, ITS PREPARATION PROCEDURE, ITS USE AS A MEDICINAL PRODUCT, AND ITS USE INTENDED FOR ANTI-CANCER TREATMENTS.
Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases